We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.78% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Canadian Natural Resources
CNQ
$97.4B
| $795K | ﹤0.01% |
+67,590
| New | +$679K |
|
|
TUP
1302
DELISTED
Tupperware Brands Corporation
TUP
| $794K | ﹤0.01% |
24,516
+3,340
| +16% | +$98.5K |
|
1303
Copa Holdings
CPA
$5.58B
| $791K | ﹤0.01% |
+10,243
| New | +$683K |
|
1304
Brookfield Renewable
BEP
$9.8B
| $789K | ﹤0.01% |
18,300
-25,839
| -59% | -$990K |
|
|
ACH
1305
Accendra Health
ACH
$107M
| $787K | ﹤0.01% |
+29,102
| New | +$749K |
|
|
GSKY
1306
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $784K | ﹤0.01% |
+169,415
| New | +$767K |
|
1307
Cooper-Standard Automotive
CPS
$504M
| $780K | ﹤0.01% |
+22,511
| New | +$626K |
|
1308
Ares Capital
ARCC
$14.3B
| $770K | ﹤0.01% |
45,596
+21,665
| +91% | +$336K |
|
1309
Nutrien
NTR
$31.6B
| $769K | ﹤0.01% |
+16,000
| New | +$707K |
|
1310
Employers Holdings
EIG
$881M
| $767K | ﹤0.01% |
+23,815
| New | +$769K |
|
|
AIFU
1311
AIFU Inc
AIFU
$220M
| $767K | ﹤0.01% |
159
-25
| -14% | -$147K |
|
1312
CVS Health
CVS
$122B
| $762K | ﹤0.01% |
11,152
-426,016
| -97% | -$27.7M |
|
1313
MannKind Corp
MNKD
$1.26B
| $762K | ﹤0.01% |
+243,345
| New | +$638K |
|
1314
Enova International
ENVA
$6.29B
| $760K | ﹤0.01% |
30,669
-107,890
| -78% | -$2.21M |
|
1315
Matthews International
MATW
$717M
| $758K | ﹤0.01% |
25,787
-93,622
| -78% | -$2.42M |
|
1316
Prothena Corp
PRTA
$468M
| $758K | ﹤0.01% |
+63,073
| New | +$746K |
|
1317
Moelis & Co
MC
$4.72B
| $755K | ﹤0.01% |
+16,168
| New | +$650K |
|
1318
Altria Group
MO
$109B
| $754K | ﹤0.01% |
18,393
-323,633
| -95% | -$13M |
|
1319
Warner Music
WMG
$13.8B
| $754K | ﹤0.01% |
+19,851
| New | +$605K |
|
1320
DexCom
DXCM
$33.1B
| $742K | ﹤0.01% |
+8,032
| New | +$717K |
|
1321
Whirlpool
WHR
$2.75B
| $740K | ﹤0.01% |
+4,100
| New | +$785K |
|
|
LTHM
1322
DELISTED
Livent Corporation
LTHM
| $734K | ﹤0.01% |
38,955
+24,515
| +170% | +$342K |
|
1323
Intellia Therapeutics
NTLA
$1.68B
| $733K | ﹤0.01% |
+13,466
| New | +$489K |
|
1324
Churchill Downs
CHDN
$6.02B
| $729K | ﹤0.01% |
+7,486
| New | +$680K |
|
1325
CareTrust REIT
CTRE
$9.55B
| $729K | ﹤0.01% |
32,833
-243,417
| -88% | -$4.79M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.